000			08157nam a22004933i 4500
001			EBC3020822
003			MiAaPQ
005			20240729124142.0
006			m o d |
007			cr cnu||||||||
008			240724s2009 xx o ||||0 eng d
020			_a9781617285868 _q(electronic bk.)
020			_z9781606929513
035			_a(MiAaPQ)EBC3020822
035			_a(Au-PeEL)EBL3020822
035			_a(CaPaEBR)ebr10680960
035			_a(OCoLC)923664487
040			_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ
050		4	_aRM302.6 -- .S83 2009eb
082	0		_a615/.704
100	1		_aRees, Janet P.
245	1	0	_aSubstance Withdrawal Syndrome.
250			_a1st ed.
264		1	_aNew York : _bNova Science Publishers, Incorporated, _c2009.
264		4	_c©2009.
300			_a1 online resource (260 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aDrug Transit and Distribution, Interception and Control Series
505	0		_aIntro -- SUBSTANCE WITHDRAWALSYNDROME -- Contents -- Preface -- Psychotropic Analgesic Nitrous Oxide[PAN] for Substance AbuseWithdrawal: Current Status -- Abstract -- Introduction - Distinguishing betweenPsychotropic Analgesic Nitrous Oxide andAnaesthetic Nitrous Oxide -- How PAN Ameliorates Substance AbuseWithdrawal States -- PAN for Treating Alcohol Withdrawal States -- Alcohol Withdrawal States -- Double-Blind, Randomised Trials with PAN versus A Benzodiazepine -- PAN for Treating Other Substances of AbuseApart from Alcohol -- Opioids -- Cocaine -- Nicotine -- Cannabis -- Polydrug Abuse -- Anti-Craving Properties of PAN -- Alcohol -- Cannabis -- Nicotine -- Current Status of PAN for Substance AbuseWithdrawal -- Credibility Gap -- Lack of Commercial Interest in PAN -- Conclusion -- Acknowledgements -- References -- Selective Serotonin ReuptakeInhibitors Withdrawal Syndromes: NewInsights into Pathophysiology andTreatment -- Abstract -- Characteristics of Discontinuation Syndromes -- The Oppositional Tolerance Model -- Long-Term Outcome of Major Depression Treated by PharmacologicalMeans -- Paradoxical Effects of Antidepressant Drugs -- Antidepressant-Induced Switching in Bipolar Disorder -- Tolerance to Antidepressant Drugs -- Antidepressant-Induced Switching in Bipolar Disorder -- Tolerance to Antidepressant Drugs -- Resistance to Antidepressant Drugs -- The Sequenced Treatment Alternatives to RelieveDepression Study (STAR*D) -- Pathophysiological Interactions -- Interaction between Different Types of Serotonin Receptors -- Interactions between Different Neurotransmitters -- Interaction between Neurotransmitter Balance and the Hypothalamic-Pituitary-Adrenal Axis -- Cross-Sensitization with Behavioral and Cognitive Phenomena -- Conclusions -- References.
505	8		_aBenzodiazepine Withdrawal Syndromeand Strategies for DiscontinuingBenzodiazepine Use: AppropriateTreatment with SSRIs and SNRIs -- Abstract -- Introduction -- Benzodiazepine Issues in Japan -- Study 1: Benzodiazepine Prescription in a Hospital -- Implications of study 1 -- Strategies for Benzodiazepine Withdrawal -- Study 2: Benzodiazepine Withdrawal Using SSRI -- Implications of Study 2 -- The Possibility of SSRI Withdrawal Syndrome -- Conclusions -- References -- Carisoprodol Withdrawal Syndrome -- Abstract -- Introduction -- Pharmacological Properites and Metabolism ofCarisoprodol -- Abuse Potential of Carisoprodol -- Early Case Reports of Carisoprodol Abuse -- Other Aspects of Carisoprodol Abuse -- Evidence of Increasing Abuse of Carisprodol -- Carisoprodol Withdrawal Syndrome -- Evidence of Withdrawal Symptoms from Early Case Reports -- Cases of Carisoprodol Withdrawal Syndrome -- Proposed Mechanism for CarisoprodolWithdrawal Symptoms -- Clinical Implications -- Controlled Substances Issues -- References -- Is Aspirin Withdrawal Detrimental forPatients with or at Risk for CoronaryArtery Disease? A Meta-Analysis -- Abstract -- Introduction -- Epidemiology of Coronary Artery Disease -- Risk-benefit balance of aspirin -- Potential hazards of aspirin withdrawal in patients with or at risk forcoronary artery disease -- Rationale and Aim of the Present Study -- Methods -- Search Strategy -- Study Selection -- Data Abstraction -- Internal Validity and Quality Appraisal -- Data Analysis and Synthesis -- Results -- Characteristics of Included Studies -- Characteristics of Excluded Studies -- Meta-Analysis -- Additional Analyses -- Discussion -- Current Clinical and Research Context -- Contributions of the Present Study -- Proposal for Management of Patients on Aspirin Undergoing InvasiveProcedures -- Limitations of the Present Study -- Conclusion.
505	8		_aAcknowledgements -- Appendix -- References -- Changes Observed in Circulatory andAlimentary Systems in AlcoholDependent Patients during theWithdrawal Period -- Abstract -- Introduction -- Consequences of Alcohol Abuse and Withdrawalin the Gastrointestinal Tract -- Cardiovascular Effect of Alcohol Withdrawal -- Main Points of Author's Reasearch Results -- Introduction -- Plasma Lipids -- Platelets -- Plasma Blood Coagulation System -- Plasma Blood Fibrinolysis System -- Nitric Oxide -- Tumor Necrosis Factor Type Alpha (TNF-alpha) -- Blood Pressure -- Heart Rate Variability -- Physical Activity -- Glucose Tolerance -- Sex Hormones -- Main Points of Authors' Studies Results -- Introduction -- The Upper Digestive Tract Morphological and Functional Status -- Esophageal Lesions -- Gastritis Features -- Gastric and Esophageal 24-hours pH-metry. Esophageal 24-hoursManometry -- Tumor Necrosis Factor Alpha (TNF-alpha) Concentration in the Aspect ofLiver Injury Pathogenesis -- References -- The Effects of Acute, Chronic andWithdrawal from Chronic Ethanol onEmotional Learning* -- Abstract -- Introduction -- Brain Areas Involved in the Modulation ofLearning by Ethanol -- Effects of Acute Ethanol on Aversive Learning -- Standard Fear Conditioning -- Trace Fear Conditioning -- Passive Avoidance -- Factors Influencing the Effects of Ethanol on Aversive Learning -- Summary -- Effects of Chronic Ethanol and Withdrawal fromChronic Ethanol on Aversive Learning -- Effects of Chronic Ethanol on Aversive Learning -- Passive Avoidance -- Fear Conditioning -- Effects of Withdrawal from Chronic Ethanol onAversive Learning -- Chronic Intermittent Ethanol and Withdrawal -- Fear Conditioning -- Passive Avoidance -- Effects of Single Withdrawal from Chronic Ethanol -- Passive Avoidance -- Post-withdrawal Effects of Ethanol on AversiveLearning -- Fear Conditioning.
505	8		_aPassive Avoidance -- Cellular Processes Underlying Ethanol-InducedMemory Deficits -- Conclusions -- References -- Topographic Brain Mapping of CaffeineUse and Caffeine Withdrawal -- Abstract -- Introduction -- The EEG during Caffeine Exposure -- The Quantitative EEG during Caffeine Withdrawal -- Other EEG Occurrences during CaffeineWithdrawal -- Cognitive Evoked Potential and CaffeineWithdrawal -- Significance of Electrophysiological Effects ofCaffeine Exposure and Withdrawal -- Conclusions -- References -- Craving, Leptin and MetabolicAssessment in Subjects with CocaineAbuse Dependence:Results from an Original Study -- Abstract -- Introduction -- Methods -- Procedure -- Leptin Dosage Procedure -- Data Analysis -- Results -- Conclusion -- Acknowledgments -- References -- Index.
588			_aDescription based on publisher supplied metadata and other sources.
590			_aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650		0	_aDrug withdrawal symptoms.
655		4	_aElectronic books.
700	1		_aWoodhouse, Olivia B.
776	0	8	_iPrint version: _aRees, Janet P. _tSubstance Withdrawal Syndrome _dNew York : Nova Science Publishers, Incorporated,c2009 _z9781606929513
797	2		_aProQuest (Firm)
830		0	_aDrug Transit and Distribution, Interception and Control Series
856	4	0	_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3020822 _zClick to View
999			_c61061 _d61061